|
TECH | Bio-Techne Corp |
|
|
TECH | Bio-Techne Corp |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.54 |
| Leverage | 19.60% |
| Market Cap | $ 11.3B |
| PE | 102.69 |
| Dividend Yield | 0.44% |
| Profit | $ 110.3m |
| Margin | 9.15% |
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.